# University Hospital, Motol

Organization · id `cardio:org-university-hospital-motol` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov sponsor names](<https://clinicaltrials.gov/search?spons=University+Hospital%2C+Motol>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 3 trials in this atlas.

## Technical summary

Sponsor class other. No ROR record matches the name exactly.

## The registry's words

- Sponsor name: University Hospital, Motol
- Sponsor class: OTHER

## Connected pages

- Sponsors: Rosuvastatin Pre-Treatment Influences the Risk of Coronary Intervention Study (`cardio:ct-nct01378715`)
- Sponsors: Catheter-directed Thrombolysis in Intermediate-high Risk Acute Pulmonary Embolism (`cardio:ct-nct05493163`)
- Sponsors: Safety and Efficacy of Low-dose Anticoagulation With Argatroban and Enoxaparin on ECMO (`cardio:ct-nct07499037`)

## Provenance

Content hash: 375c716fd059319a3c7e092f35a7755310b929d401ee6c64071776820182be0c
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
